KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Edwards Lifesciences (EW) Net Margin (2016 - 2025)

Historic Net Margin for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to 0.13%.

  • Edwards Lifesciences' Net Margin fell 2000200.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year decrease of 516500.0%. This contributed to the annual value of 50.99% for FY2024, which is 474100.0% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Net Margin of 0.13% as of Q3 2025, which was down 2000200.0% from 0.29% recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Net Margin high stood at 199.89% for Q3 2024, and its period low was 0.51% during Q1 2025.
  • Moreover, its 5-year median value for Net Margin was 25.22% (2021), whereas its average is 28.08%.
  • Per our database at Business Quant, Edwards Lifesciences' Net Margin skyrocketed by 1959600bps in 2024 and then plummeted by -2000200bps in 2025.
  • Edwards Lifesciences' Net Margin (Quarter) stood at 25.22% in 2021, then surged by 268bps to 92.67% in 2022, then crashed by -97bps to 2.89% in 2023, then dropped by -2bps to 2.84% in 2024, then plummeted by -105bps to 0.13% in 2025.
  • Its last three reported values are 0.13% in Q3 2025, 0.29% for Q2 2025, and 0.51% during Q1 2025.